Back to Search
SANJAY SETHI, MD
MD
Internal Medicine Physician
NPI: 1679595862IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
184124(NY)
Critical Care Medicine (Internal Medicine) Physician
Internal Medicine — Critical Care Medicine
Code: 207RC0200X
184124(NY)
Pulmonary Disease Physician
Internal Medicine — Pulmonary Disease
Code: 207RP1001X
184124(NY)
CMS Specialties
PrimaryPULMONARY DISEASE
Education
OTHER
Class of 1984
Research & Publications (20)
The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et al.
PMID 18847482·BMC Med·2008
8-other
Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease.
PMID 18079493·Am J Respir Crit Care Med·2008
8-other
Infection in the pathogenesis and course of chronic obstructive pulmonary disease.
PMID 19038881·N Engl J Med·2008
6-review
Airway bacterial concentrations and exacerbations of chronic obstructive pulmonary disease.
PMID 17478618·Am J Respir Crit Care Med·2007
8-other
Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease.
PMID 16474030·Am J Respir Crit Care Med·2006
8-other
Antibiotic activity of telithromycin and comparators against bacterial pathogens isolated from 3,043 patients with acute exacerbation of chronic bronchitis.
PMID 15755326·Ann Clin Microbiol Antimicrob·2005
8-other
Pathogenesis and treatment of acute exacerbations of chronic obstructive pulmonary disease.
PMID 16088436·Semin Respir Crit Care Med·2005
4-observational
Moxifloxacin for the treatment of acute exacerbations of chronic obstructive pulmonary disease.
PMID 15942884·Clin Infect Dis·2005
4-observational
Efficacy and safety of pharmacokinetically enhanced amoxicillin-clavulanate at 2,000/125 milligrams twice daily for 5 days versus amoxicillin-clavulanate at 875/125 milligrams twice daily for 7 days in the treatment of acute exacerbations of chronic bronchitis.
PMID 15616290·Antimicrob Agents Chemother·2005
3-trial
Managing patients with recurrent acute exacerbations of chronic bronchitis: a common clinical problem.
PMID 15462685·Curr Med Res Opin·2004
6-review
Bacteria in exacerbations of chronic obstructive pulmonary disease: phenomenon or epiphenomenon?
PMID 16113422·Proc Am Thorac Soc·2004
6-review
Acute exacerbations of chronic bronchitis: new developments concerning microbiology and pathophysiology--impact on approaches to risk stratification and therapy.
PMID 15555829·Infect Dis Clin North Am·2004
6-review
A randomized, double-blind study comparing 5 days oral gemifloxacin with 7 days oral levofloxacin in patients with acute exacerbation of chronic bronchitis.
PMID 15303633·Respir Med·2004
3-trial
New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease.
PMID 15021050·Curr Opin Infect Dis·2004
6-review
Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease.
PMID 14597486·Am J Respir Crit Care Med·2004
8-other
Gatifloxacin in community-acquired respiratory tract infection.
PMID 14521494·Expert Opin Pharmacother·2003
6-review
The Role of Antibiotics in Acute Exacerbations of Chronic Obstructive Pulmonary Disease.
PMID 12525285·Curr Infect Dis Rep·2003
8-other
New strains of bacteria and exacerbations of chronic obstructive pulmonary disease.
PMID 12181400·N Engl J Med·2002
8-other
Bacterial pneumonia. Managing a deadly complication of influenza in older adults with comorbid disease.
PMID 11899549·Geriatrics·2002
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3495 BAILEY AVE
BUFFALO, NY 14215 - Phone
- (716) 862-7875
Quick Facts
- NPI
- 1679595862
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 3
- Locations
- 1
- Years in Practice
- 42
- Publications
- 20
Are you this provider?
Claim Your Profile